Polaryx Therapeutics, Inc.
PLYX· Nasdaq
Released May 14, 2026, after the close
10-Q filed May 15, 2026, 45 days after period end · 0001213900-26-056973
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Income | -$2.54M | -$5.05M |
| EPS Diluted | -$0.05 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Polaryx Therapeutics, Inc. · CIK 2075320 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end
21.7% from the close of May 14, 2026 to the close of May 15, 2026, the first after the release.